These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9265384)

  • 41. [Management of heparin-induced thrombocytopenia in a patient on hemodialysis complicated with thrombosis in the extracorporeal circuit].
    César JM; Candela A; Tenorio MT; Chinea A; Sáiz R; Liaño F
    Nefrologia; 2008; 28(4):462-3. PubMed ID: 18662159
    [No Abstract]   [Full Text] [Related]  

  • 42. Combination platelet glycoprotein IIb/IIIa receptor and lepirudin administration during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Pinto DS; Sperling RT; Tu TM; Cohen DJ; Carrozza JP
    Catheter Cardiovasc Interv; 2003 Jan; 58(1):65-8. PubMed ID: 12508198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bivalirudin use in carotid endarterectomy in a patient with heparin-induced thrombocytopenia.
    Finks SW
    Ann Pharmacother; 2006 Feb; 40(2):340-3. PubMed ID: 16449539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
    Kiser TH; Jung R; MacLaren R; Fish DN
    Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heparin-induced thrombocytopenia: advances in diagnosis and treatment.
    Cooney MF
    Crit Care Nurse; 2006 Dec; 26(6):30-6; quiz 37. PubMed ID: 17123949
    [No Abstract]   [Full Text] [Related]  

  • 47. Heparin-induced thrombocytopenia in a patient treated with fondaparinux.
    Ratuapli SK; Bobba B; Zafar H
    Clin Adv Hematol Oncol; 2010 Jan; 8(1):61-5. PubMed ID: 20351685
    [No Abstract]   [Full Text] [Related]  

  • 48. Bivalirudin anticoagulation for a patient with hypercoagulable immune syndromes undergoing mitral valve surgery.
    Cain RL; Spiess BD; Nelson M; Deanda A; McCarthy HL; Green JA
    Ann Thorac Surg; 2006 Jun; 81(6):2308-10. PubMed ID: 16731183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful use of low dose r-hirudin (Refludan) for recurrent dialysis catheter thrombosis in a patient with heparin induced thrombocytopenia.
    Patel VB; Snyder J; Shopnick RI
    Thromb Haemost; 1999 Sep; 82(3):1205-6. PubMed ID: 10494796
    [No Abstract]   [Full Text] [Related]  

  • 50. Successful treatment of heparin-associated thrombocytopenia and thrombosis using Hirulog.
    Chamberlin JR; Lewis B; Leya F; Wallis D; Messmore H; Hoppensteadt D; Walenga JM; Moran S; Fareed J; McKiernan T
    Can J Cardiol; 1995 Jun; 11(6):511-4. PubMed ID: 7780873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of lepirudin in haemodialysis complicated with heparin-induced thrombocytopenia type II (HIT II)--dosage monitoring.
    Kassimatis TI; Apostolou T; Theodoridis T; El Ali M; Hadjiconstantinou V
    Nephrol Dial Transplant; 2006 Nov; 21(11):3341-2. PubMed ID: 16822790
    [No Abstract]   [Full Text] [Related]  

  • 52. Re-exposure to heparin in uremic patients requiring hemodialysis with heparin-induced thrombocytopenia.
    Wanaka K; Matsuo T; Matsuo M; Kaneko C; Miyashita K; Asada R; Matsushima H; Nakajima Y
    J Thromb Haemost; 2010 Mar; 8(3):616-8. PubMed ID: 20050999
    [No Abstract]   [Full Text] [Related]  

  • 53. Fulminate heparin-induced thrombocytopenia and surgery with deep hypothermic circulatory arrest using bivalirudin.
    Koster A; Amin-Parsa M; Kaufmann M; Meyer-Jark T; Rudloff M; Diekmann J; Georg WM; Liebke M; Schirmer U; Gummert JF
    Ann Thorac Surg; 2013 Mar; 95(3):1079-81. PubMed ID: 23438537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term anticoagulation with recombinant hirudin in a patient on left ventricular assist device support.
    Tandler R; Weyand M; Schmid C; Gradaus R; Schmidt C; Scheld HH
    ASAIO J; 2000; 46(6):792-4. PubMed ID: 11110284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia.
    Kiser TH; Burch JC; Klem PM; Hassell KL
    Pharmacotherapy; 2008 Sep; 28(9):1115-24. PubMed ID: 18752382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comment: treatment of heparin-induced thrombocytopenia.
    Smythe MA; Warkentin TE
    Ann Pharmacother; 2002 Sep; 36(9):1483-4; author reply 1484. PubMed ID: 12196076
    [No Abstract]   [Full Text] [Related]  

  • 57. [Heparin-induced thrombocytopenia in patients on hemodialysis].
    Matsuo T
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():312-8. PubMed ID: 15250315
    [No Abstract]   [Full Text] [Related]  

  • 58. [Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].
    Devignes J; de Maistre E; Grosjean S; Walter AF; Hacquard M; Mulot A; Longrois D; Carteaux JP; Lecompte T
    Ann Biol Clin (Paris); 2005; 63(2):201-8. PubMed ID: 15771978
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A case of heparin induced thrombocytopenia treated with lepirudin infusion: case report].
    Sünmez S; Okumuş G; Kiyan E; Ece T; Arseven O
    Tuberk Toraks; 2006; 54(2):185-8. PubMed ID: 16924578
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of heparin, bivalirudin, and different glycoprotein IIb/IIIa inhibitor regimens for anticoagulation during percutaneous coronary intervention: A network meta-analysis.
    Lipinski MJ; Lee RC; Gaglia MA; Torguson R; Garcia-Garcia HM; Pichard AD; Satler LF; Waksman R
    Cardiovasc Revasc Med; 2016 Dec; 17(8):535-545. PubMed ID: 27842901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.